Drug Shortage Report for AVELOX I.V.

Last updated on 2018-02-27 History
Report ID 12543
Drug Identification Number 02246414
Brand name AVELOX I.V.
Common or Proper name moxifloxacin injection
Company Name BAYER INC
Active Ingredient(s) MOXIFLOXACIN
Strength(s) 400MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 250 mL Ready-to-use minibag
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-06-30
Actual start date
Estimated end date 2018-03-29
Actual end date 2018-02-23
Shortage status Resolved
Updated date 2018-02-27
Company comments Avelox I.V. is now in bottle and available to the market.
Health Canada comments
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2018-02-27 French Compare
v6 2018-02-27 English Compare
v5 2018-02-27 French Compare
v4 2018-02-27 English Compare
v3 2017-07-01 English Compare
v2 2017-06-12 French Compare
v1 2017-06-12 English Compare